Jazz Pharmaceuticals plc
JAZZ나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
5건
최근 2026.11.03
90일 내부자 순매수
-36억 8,196만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 11건
- US미국정기보고서중요도 보통어제10-Q · Quarterly report
Jazz Pharmaceuticals plcJAZZ
10-Q · 2026.11.03 06:09 KST
- US미국실적중요도 보통어제8-K · Current report (Items 2.02, 9.01)
Jazz Pharmaceuticals plcJAZZ
8-K · 2026.11.03 06:07 KST
- US미국실적중요도 보통2026.10.278-K · Current report (Items 2.02)
Jazz Pharmaceuticals plcJAZZ
8-K · 2026.10.27 05:03 KST
- US미국지배구조·주총중요도 보통2026.10.098-K · Current report (Items 5.02)
Jazz Pharmaceuticals plcJAZZ
8-K · 2026.10.09 22:02 KST
- US미국임원·주요주주 소유중요도 보통2026.10.074 · Statement of changes in beneficial ownership
Jazz Pharmaceuticals plcJAZZ
Form 4 · 2026.10.07
- US미국임원·주요주주 소유중요도 높음2026.10.054 · Statement of changes in beneficial ownership
Jazz Pharmaceuticals plcJAZZ
Form 4 · 2026.10.05
- US미국주요사항·수시공시중요도 높음2026.09.248-K · Current report (Items 1.01, 2.03, 9.01)
Jazz Pharmaceuticals plcJAZZ
8-K · 2026.09.24 05:15 KST
- US미국주요사항·수시공시중요도 낮음2026.09.158-K · Current report (Items 7.01)
Jazz Pharmaceuticals plcJAZZ
8-K · 2026.09.15 22:06 KST
- US미국임원·주요주주 소유중요도 보통2026.09.144 · Statement of changes in beneficial ownership
Jazz Pharmaceuticals plcJAZZ
Form 4 · 2026.09.14
- US미국임원·주요주주 소유중요도 낮음2026.09.104 · Statement of changes in beneficial ownership
Jazz Pharmaceuticals plcJAZZ
Form 4 · 2026.09.10